Welcome
Support Centre
04 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Acquired immune deficiency syndrome (AIDS) prevention through reduced choice disability
ISRCTN ISRCTN28557578
ClinicalTrials.gov identifier
Public title Acquired immune deficiency syndrome (AIDS) prevention through reduced choice disability
Scientific title Acquired immune deficiency syndrome (AIDS) prevention in favour of the choice disabled: a randomised controlled trial to reduce human immunodeficiency virus (HIV) risk in southern Africa
Acronym NOCHOICE
Serial number at source N/A
Study hypothesis Why a trial is needed:
Almost all interventions currently addressing acquired immune deficiency syndrome (AIDS) are geared for those who can act on their prevention decisions. Although a recent randomised controlled trial (RCT) showed reduction of sexual violence with an economic intervention, it is not known how this might affect human immunodeficiency virus (HIV) rates. There is little research on complex interventions in AIDS prevention, yet all countries in the region implement multiple intervention prevention programmes.

The issue:
Reduce HIV risk through reducing choice disablement or ameliorating its worst effects on AIDS though sensitisation of local AIDS prevention efforts and economic empowerment. After implementation in Botswana, the eventual objective is a 10-country controlled trial to demonstrate the impact of concerting public services in favour of the choice disabled, primary prevention of sexual violence and economic empowerment.

Please note that as of 24/02/2009 this record has been amended to include a new end date; the inital information at time of registration was as follows:
Initial anticipated end date: 01/09/2012
At this time, the acronym was also changed from 'BART2' to 'NOCHOICE'.
Lay summary
Ethics approval Added 24/02/2009:
1. Botswana Ministry of Health gave approval on the 26th August 2008 (ref: PPME-13/18/1 Vol IV(4))
2. Namibia Ministry of Health and Social Services gave approval on the 22nd July 2008 (ref: 17/3/3AP)
3. Swaziland Ministry of Health gave approval on the 26th August 2008 (ref: MH/599B)
Study design Cluster randomised controlled four-arm factorial trial
Countries of recruitment Botswana, Namibia, Swaziland
Disease/condition/study domain Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
Participants - inclusion criteria 79 nationally representative clusters (100 - 120 households) randomly selected (from population census) enumeration areas.
Participants - exclusion criteria Does not comply with inclusion criteria
Anticipated start date 01/09/2008
Anticipated end date 30/08/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 79 clusters
Interventions Four interventions, alone and in combination:
1. Optimises local private-public networks to reduce HIV risk in favour of those who cannot implement their prevention choices
2. Sexual violence education through schools, youth groups, granny groups, church groups and local radio, geared to generate endogenous community-specific solutions to reduce sexual violence
3. Focuses on empowerment of the choice disabled through the Organisational Workshop approach
4. Promotion of male circumcision

The interventions will run concurrently for three years, with a follow-up survey in the fourth year.
Primary outcome measure(s) The 2007 baseline and follow-up survey in year 4 will measure reduced sexual violence and HIV infection in women aged 18 - 29 years. Follow-up of a male (18 - 29 years) cohort established in 2008 will establish the impact of promoting male circumcision (MC), alone and in combination with other activities.

All will be measured in the fourth year.
Secondary outcome measure(s) All will be measured in the fourth year:
1. Protective knowledge
2. Attitudes
3. Subjective norms
4. Intention to change
5. Agency
6. Discussion of prevention
7. Practices related to sexual violence

Likely side effects of the intervention include reduced criminal delinquency and substance abuse.
Sources of funding International Development Research Centre (IDRC) (Canada)
Trial website
Publications
Contact name Dr  Neil  Andersson
  Address 1 Stewart Street
Room 319
  City/town Ottawa
  Zip/Postcode K1N 6N5
  Country Canada
Sponsor International Development Research Centre (IDRC) (Canada)
  Address PO Box 8500
  City/town Ottawa
  Zip/Postcode K1G 3H9
  Country Canada
  Sponsor website: http://www.idrc.ca/index_en.html
Date applied 12/06/2008
Last edited 24/02/2009
Date ISRCTN assigned 13/08/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central